Loading…
Loading…

Align Technology Inc
NASDAQ · Stock Profile · Market Cap $12.37B
Current Price
$172.41
-2.11%GoodMoat Value
$138.79
19.5% overvaluedPrice sits at 58% of its 52-week range.
Forward estimates use 29.0% FCF growth (CAGR)
Net Cash: 1.0B
1.0B
FY24
978M
FY24
4.0B
FY24
979M
FY25
1.0B
FY25
996M
FY25
4.0B
FY25
97M
FY24
116M
FY24
421M
FY24
93M
FY25
125M
FY25
57M
FY25
410M
FY25
Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Country
California, USA
Earnings per share grew at a 29.0% CAGR.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Country
California, USA